Dopamine d2 Receptor Anticorps
(Dopamine Receptor D2 (DRD2))
Choisissez l’un des 99 anticorps Dopamine d2 Receptor de notre liste de produits basés sur 9 publications et 27 images de validation.
Découvrez des anticorps Dopamine d2 Receptor fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de Dopamine d2 Receptor dans plusieurs espèces, y compris Human, Rat, Mouse, Dog, Monkey, Bat, Chemical, Cow, Horse, Rabbit, et prend en charge diverses applications de recherche telles que WB, IF (cc), IF (p), ELISA, IHC.
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants Dopamine d2 Receptor, issus de différents hôtes tels que Rabbit, Mouse, Human. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de Dopamine d2 Receptor sont DRD2, drd2l, drd2, Drd2, drd2.L, drd2.S, Dop1R2.
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| Dopamine d2 Receptor anticorps (Extracellular, N-Term) | Humain, Rat, Souris | Lapin Polyclonal |
|
1.466,46 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (3rd Cytoplasmic Domain) | Humain, Singe | Lapin Polyclonal |
|
649,20 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (Cytosolic, Long Isoform) | Rat | Souris Monoclonal |
|
611,20 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (C-Term) | Humain, Souris | Lapin Polyclonal |
|
821,15 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (C-Term) | Humain | Lapin Polyclonal |
|
948,75 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (C-Term) (PE) | Humain | Lapin Polyclonal |
|
1.193,54 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (Cytosolic, Long Isoform) (FL550) | Rat | Souris Monoclonal |
|
849,60 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (Cytosolic, Long Isoform) (FL490) | Rat | Souris Monoclonal |
|
849,60 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (Cytosolic, Long Isoform) (FL594) | Rat | Souris Monoclonal |
|
849,60 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (Cytosolic, Long Isoform) | Rat | Souris Monoclonal |
|
849,60 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (Cytosolic, Long Isoform) (FL650) | Rat | Souris Monoclonal |
|
849,60 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (Cytoplasmic Domain) | Humain | Lapin Polyclonal |
|
529,40 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (AA 194-421) | Souris | Lapin Polyclonal |
|
425,19 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (C-Term) | Humain, Souris | Lapin Polyclonal |
|
439,56 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps | Humain, Rat, Souris | Lapin Polyclonal |
|
185,90 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps | Rat, Souris | Souris Monoclonal |
|
426,80 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (APC) | Humain | Human Monoclonal |
|
363,00 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps | Humain | Human Monoclonal |
|
426,80 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (FITC) | Humain | Human Monoclonal |
|
363,00 €
Voir le prix
|
|
| Dopamine d2 Receptor anticorps (PE) | Humain | Human Monoclonal |
|
363,00 €
Voir le prix
|
Primary Antibody
- M (Molecule: Image de validation disponible)
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- LCI (Live Cell Imaging: Application indiquée)
- Classe de qualité
- Carrier-free
- Reactivité
- Humain, Rat, Souris
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- AA 11-26, Extracellular, N-Term
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain, Singe
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- 3rd Cytoplasmic Domain
Primary Antibody
- IHC (Immunohistochemistry: Image de validation disponible)
- ELISA (ELISA: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- Reactivité
- Rat
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- N186-29
- Conjugué
- unconjugated
- Isotype
- IgG1
- Epitope
- AA 211-374, Cytosolic, Long Isoform
Primary Antibody
- WB (Western Blotting: Image de validation disponible)
- EIA (Enzyme Immunoassay: Application indiquée)
- Reactivité
- Humain, Souris
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- Ig Fraction
- Epitope
- C-Term, AA 306-336
Primary Antibody
- WB (Western Blotting: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- C-Term, AA 306-336
Primary Antibody
- WB (Western Blotting: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- PE
- Isotype
- IgG
- Epitope
- C-Term, AA 306-336
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- Reactivité
- Rat
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- N186-29
- Conjugué
- FL550
- Isotype
- IgG1
- Epitope
- AA 211-374, Cytosolic, Long Isoform
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- Reactivité
- Rat
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- N186-29
- Conjugué
- FL490
- Isotype
- IgG1
- Epitope
- AA 211-374, Cytosolic, Long Isoform
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- Reactivité
- Rat
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- N186-29
- Conjugué
- FL594
- Isotype
- IgG1
- Epitope
- AA 211-374, Cytosolic, Long Isoform
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Classe de qualité
- Carrier-free
- Reactivité
- Rat
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- N186-29
- Conjugué
- unconjugated
- Isotype
- IgG1
- Epitope
- AA 211-374, Cytosolic, Long Isoform
Primary Antibody
- IHC (Immunohistochemistry: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- Reactivité
- Rat
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- N186-29
- Conjugué
- FL650
- Isotype
- IgG1
- Epitope
- AA 211-374, Cytosolic, Long Isoform
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Epitope
- Cytoplasmic Domain
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- IP (Immunoprecipitation: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- Reactivité
- Souris
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Epitope
- AA 194-421
Primary Antibody
- Reactivité
- Humain, Souris
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Epitope
- AA 307-336, C-Term
Primary Antibody
- Reactivité
- Humain, Rat, Souris
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
Primary Antibody
- Reactivité
- Rat, Souris
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- SAA0784
- Conjugué
- unconjugated
- Isotype
- IgG2a, kappa
Primary Antibody
- Reactivité
- Humain
- Hôte
- Human
- Clonalité
- Monoclonal
- Clone
- ABS0064
- Conjugué
- APC
Primary Antibody
- Reactivité
- Humain
- Hôte
- Human
- Clonalité
- Monoclonal
- Clone
- SAA0772
- Conjugué
- unconjugated
Primary Antibody
- Reactivité
- Humain
- Hôte
- Human
- Clonalité
- Monoclonal
- Clone
- ABS0064
- Conjugué
- FITC
Primary Antibody
- Reactivité
- Humain
- Hôte
- Human
- Clonalité
- Monoclonal
- Clone
- ABS0064
- Conjugué
- PE
Dernières publications pour nos Dopamine d2 Receptor Anticorps
: "Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway." dans: Marine drugs, Vol. 16, Issue 3, (2018) (PubMed).
: "Effect of Gingerol on Cisplatin-Induced Pica Analogous to Emesis Via Modulating Expressions of Dopamine 2 Receptor, Dopamine Transporter and Tyrosine Hydroxylase in the Vomiting Model of Rats." dans: Yonago acta medica, Vol. 59, Issue 2, pp. 100-10, (2016) (PubMed).
: "Mixed Pituitary Gangliocytoma and Prolactinoma Resistant to the Cabergoline Treatment." dans: World neurosurgery, Vol. 95, pp. 620.e17-620.e22, (2016) (PubMed).
: "Moderate swimming suppressed the growth and metastasis of the transplanted liver cancer in mice model: with reference to nervous system." dans: Oncogene, Vol. 35, Issue 31, pp. 4122-31, (2016) (PubMed).
: "Dopamine D2 receptor blocker thioridazine induces cell death in human uterine cervical carcinoma cell line SiHa." dans: The journal of obstetrics and gynaecology research, Vol. 41, Issue 8, pp. 1240-5, (2015) (PubMed).
: "Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role." dans: Neuroendocrinology, Vol. 101, Issue 3, pp. 211-22, (2015) (PubMed).
: "Perfluorooctane sulfonate (PFOS) exposure could modify the dopaminergic system in several limbic brain regions." dans: Toxicology letters, Vol. 240, Issue 1, pp. 226-35, (2015) (PubMed).
: "Increased extracellular dopamine and 5-hydroxytryptamine levels contribute to enhanced subthalamic nucleus neural activity during exhausting exercise." dans: Biology of sport, Vol. 32, Issue 3, pp. 187-92, (2015) (PubMed).
: "Dopamine D1 receptor activation induces dehydroepiandrosterone sulfotransferase (SULT2A1) in HepG2 cells." dans: Acta pharmacologica Sinica, Vol. 35, Issue 7, pp. 889-98, (2014) (PubMed).
: "Targeting dopamine receptors subtype 2 (D2DR) in pheochromocytomas: head-to-head comparison between in vitro and in vivo findings." dans: The Journal of clinical endocrinology and metabolism, Vol. 98, Issue 12, pp. E1951-5, (2013) (PubMed).
: "Effect of Gingerol on Cisplatin-Induced Pica Analogous to Emesis Via Modulating Expressions of Dopamine 2 Receptor, Dopamine Transporter and Tyrosine Hydroxylase in the Vomiting Model of Rats." dans: Yonago acta medica, Vol. 59, Issue 2, pp. 100-10, (2016) (PubMed).
: "Mixed Pituitary Gangliocytoma and Prolactinoma Resistant to the Cabergoline Treatment." dans: World neurosurgery, Vol. 95, pp. 620.e17-620.e22, (2016) (PubMed).
: "Moderate swimming suppressed the growth and metastasis of the transplanted liver cancer in mice model: with reference to nervous system." dans: Oncogene, Vol. 35, Issue 31, pp. 4122-31, (2016) (PubMed).
: "Dopamine D2 receptor blocker thioridazine induces cell death in human uterine cervical carcinoma cell line SiHa." dans: The journal of obstetrics and gynaecology research, Vol. 41, Issue 8, pp. 1240-5, (2015) (PubMed).
: "Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role." dans: Neuroendocrinology, Vol. 101, Issue 3, pp. 211-22, (2015) (PubMed).
: "Perfluorooctane sulfonate (PFOS) exposure could modify the dopaminergic system in several limbic brain regions." dans: Toxicology letters, Vol. 240, Issue 1, pp. 226-35, (2015) (PubMed).
: "Increased extracellular dopamine and 5-hydroxytryptamine levels contribute to enhanced subthalamic nucleus neural activity during exhausting exercise." dans: Biology of sport, Vol. 32, Issue 3, pp. 187-92, (2015) (PubMed).
: "Dopamine D1 receptor activation induces dehydroepiandrosterone sulfotransferase (SULT2A1) in HepG2 cells." dans: Acta pharmacologica Sinica, Vol. 35, Issue 7, pp. 889-98, (2014) (PubMed).
: "Targeting dopamine receptors subtype 2 (D2DR) in pheochromocytomas: head-to-head comparison between in vitro and in vivo findings." dans: The Journal of clinical endocrinology and metabolism, Vol. 98, Issue 12, pp. E1951-5, (2013) (PubMed).
Pseudonymes pour Dopamine d2 Receptor Anticorps
dopamine receptor D2 (DRD2) Anticorpsdopamine receptor D2 like (drd2l) Anticorps
dopamine receptor D2 (drd2) Anticorps
dopamine receptor D2 (Drd2) Anticorps
dopamine receptor D2 L homeolog (drd2.L) Anticorps
dopamine receptor D2 S homeolog (drd2.S) Anticorps
Dopamine 1-like receptor 2 (Dop1R2) Anticorps
CG7569 Anticorps
CG18741 Anticorps
D2 Anticorps
D2DR Anticorps
d2dr Anticorps
D2R Anticorps
d2r Anticorps
d2r2 Anticorps
DAMB Anticorps
Dar2 Anticorps
DDR2 Anticorps
Dmel\\CG18741 Anticorps
DopD1 Anticorps
DOPR2 Anticorps
DOPR99B Anticorps
DopR99B Anticorps
DopRII Anticorps
Drd-2 Anticorps
drd2 Anticorps
DRD2 Anticorps
drd2-B Anticorps
drd2b Anticorps
Avez-vous cherché autre chose?
- Dopamine Anticorps
- DONSON Anticorps
- DOM3Z Anticorps
- DOLPP1 Anticorps
- Dolichol Kinase Anticorps
- DOK7 Anticorps
- DOK6 Anticorps
- DOK5 Anticorps
- DOK4 Anticorps
- DOK3 Anticorps
- DOK2 Anticorps
- DOK1 Anticorps
- DOHH Anticorps
- DOCK9 Anticorps
- DOCK8 Anticorps
- DOCK7 Anticorps
- DOCK6 Anticorps
- Dock5 Anticorps
- DOCK4 Anticorps
- DOCK3 Anticorps
- Dopamine Receptor d1 Anticorps
- Dopamine Receptor D3 Anticorps
- Dopamine Receptor D4 Anticorps
- DOPEY1 Anticorps
- DOPEY2 Anticorps
- DOT1L Anticorps
- Double-stranded RNA-binding protein Staufen homolog 2 Anticorps
- Doublecortin Anticorps
- Doublesex Anticorps
- Doublesex and Mab-3 Related Transcription Factor 1 Anticorps
- Doublesex and Mab-3 Related Transcription Factor 2 Anticorps
- Doublesex and Mab-3 Related Transcription Factor 3 Anticorps
- DP2 Anticorps
- DPAGT1 Anticorps
- DPCD Anticorps
- DPCR1 Anticorps
- DPEP1 Anticorps
- DPEP2 Anticorps
- DPEP3 Anticorps
- DPF1 Anticorps
Vous êtes ici:
